It's been quite the volatile year so far in the stock market; it
appears that after rebounding fantastically from the lows in
early 2009, the stock market has met our nascent economic
recovery head-on in a confrontational "prove it to me" moment.
Most investors know they want to continue participating in the
market, but a 15% decline since April has many of us reaching
for the antacids.  The following stocks may prove to be a
soothing option for both the nervous and the opportunistic. They
are culled from a screen that filtered for a track record of
good growth, below average market valuations and strong balance
sheets.  Official Parameters:  * A market capitalization above
$2 billion;  * Above 15% on each of these three metrics: five-
year earnings growth, return on equity and operating margins;  *
Current ratio > 1.0 (this is the ratio of current assets to
current liabilities, with results over 1 a nod to balance sheet
stability);  * Forward P/E ratio under 13 times estimates, which
is the current level of t